Cabinet defers decision on new pharma policy

The Cabinet today deferred the decision on the draft pharmaceutical pricing policy that aims to increase the number of essential medicines under price control from 74 to 348.

November 08, 2012 / 21:21 IST

The Cabinet today deferred the decision on the draft pharmaceutical pricing policy that aims to increase the number of essential medicines under price control from 74 to 348. "The decision on the pharma policy has been deferred," Finance Minister P Chidambaram told reporters after the Cabinet meeting.

Under the draft pharmaceutical pricing policy approved by the group of ministers, headed by Agriculture Minister Sharad Pawar, prices of 348 essential medicines will be controlled. That apart, the draft policy aims at fixing prices based on weighted average of prices of all brands, which have more than 1 per cent market share.

Currently, 74 medicines are under price control. Last month, the Supreme Court had, however, asked the government not to alter the existing mechanism of cost-based drug pricing.

first published: Nov 8, 2012 08:04 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

Al Edge Newsletter On Saturdays

Find the best of Al News in one place, specially curated for you every weekend.
MC Tech 3 Newsletter Daily-Weekdays

Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347